CORDIS
EU research results

CORDIS

English EN

Diagnostic and Drug Discovery Initiative for Alzheimer’s Disease

Project information

Grant agreement ID: 612347

Status

Closed project

  • Start date

    1 October 2014

  • End date

    30 September 2018

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 208 897,95

  • EU contribution

    € 2 208 897,95

Coordinated by:

THE UNIVERSITY OF SHEFFIELD

United Kingdom

Objective

Alzheimer’s disease (AD) is the major cause of dementia which has no cure at the moment. The overall aim of the work described in this proposal is to create a long-term strategic partnership between Sheffield University (UK), Lisbon University (Portugal), Eli Lilly (UK) and Biofordrug (Italy) in order to develop chemical biology tools for better understanding the role of PrPC in AD and harnessing this understanding to develop novel chemical entities for diagnostic and therapeutics applications.

The D3i4AD project brings together a consortium of groups with internationally-leading expertise from academia and industries in chemistry, molecular design and modelling, biochemistry, diagnostic and drug development. Our proposed programme will lead to major increases in the knowledge and capacity of all consortium members, achieved through significant intersectoral exchange of personnel between the partners over the duration of the project (total 134 person months) and through temporary recruitment of 5 new experienced researchers (total 114 person months). The project will thus underpin a substantial programme of intersectoral knowledge transfer and research training and lead to significant innovation and advances in several areas of basic research as well as diagnostics and therapeutics development. These activities will strongly enhance EU standing and international competitiveness in this extremely challenging and increasingly important technological area.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

THE UNIVERSITY OF SHEFFIELD

Address

Firth Court Western Bank
S10 2tn Sheffield

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 009 134,94

Administrative Contact

Andrew King (Mr.)

Participants (4)

Eli Lilly and Company Limited

United Kingdom

EU Contribution

€ 290 164,16

BIOFORDRUG SRL

Italy

EU Contribution

€ 449 415,60

FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA

Portugal

EU Contribution

€ 399 591,50

AMORFIX LIFE SCIENCES LTD

Canada

EU Contribution

€ 60 591,75

Project information

Grant agreement ID: 612347

Status

Closed project

  • Start date

    1 October 2014

  • End date

    30 September 2018

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 208 897,95

  • EU contribution

    € 2 208 897,95

Coordinated by:

THE UNIVERSITY OF SHEFFIELD

United Kingdom